The Hybritech Alumni: Where Are They Now?

Paulette Roper, senior manager of eSolutions, Allergan

Paul Rosinack, president & CEO, Qualigen [Added: 9:25 am, 3/15/10]

Ivor Royston, managing member, Forward Ventures

Kale Ruby, vice president of CMC and Quality Assurance, MediciNova

Jane Ryskamp, vice president, global supply chain, Amylin Pharmaceuticals [Added: 7 pm, 3/18/10]

H.F. “Butch” Sanders, senior operations/product management executive

Mark Sarno, president, Vision Biotechnology Consulting [Added: 8:05 pm, 3/14/10]

Charles Schaus, project manager, Eurogentec

Lou Schioppi, senior business development manager, Patheon Pharmaceuticals

Scott Schubert, senior technical operations scientist, Beckman Coulter [Added: 7 pm, 3/18/10]

Blair Shamel, president, The Shamel Group

Mark Shannon, president, Quadrants Scientific

Hal Siegel, vice president and chief scientific officer, ImmuneRegen Biosciences [Added: 4:08 pm, 3/14/10]

Linda Simmons, senior business analyst, global supply chain, Amylin Pharmaceuticals

Paul Skoczelas, senior manager, trade relations, Prometheus Laboratories [Added: 9:25 am, 3/15/10]

Diane Smith, owner, All Track [Added: 2:50 pm, 3/15/10]

William Soo Hoo, vice president, Jaden Bioscience

Grace Soriano, biotechnology professional

Paula Southwick, group manager of clinical research, Beckman Coulter

Sharron Starkey, director of QA/RA, Accumetrics

Barb Stevens, owner, Stevens and Associates [Added: 2:30 pm, 3/14/10]

Richard Stewart, owner, Stewart ComGraph [Added: 8:05 pm, 3/14/10]

Susan Strobel, principal writer, SciComm

Dean Tallam, president, Syndeo [Added: 3:40 pm, 7/7/10]

Daria Tansey, biotechnology professional, retired [Added: 9:25 am, 3/15/10]

Ron Taylor, board member, ResMed, Watson Pharmaceuticals, 3E, EMN8, Safelife [Added: 5:30 pm, 3/14/10]

Bruce Tedeschi, CEO, Digibroker [Added: 8:05 pm, 3/14/10]

Lynn Terhorst, consultant

Michael Ternavan, biotechnology professional

Judy Thompson, buyer II, Inova Diagnostics

Keith Timm, owner, Timm & Associates

Betty Tran, pharmaceutical consultant

Barbara Unger, director, corporate quality compliance, Amgen [Added, 2:30 pm, 3/14/10]

Michael Unger, director, project management & strategic operations, Amgen [Added: 2:45 pm, 3/15/10]

Janice (Hillesheim) Valdivia, office administrator, Forward Ventures [Added: 7 pm, 3/18/10]

Gunars Valkirs, former SVP of discovery and co-founder, Biosite. [Added: 1:15 pm 3/12/10]

Brent Vaughan, chief business officer, KineMed

Patrick Walsh, biotechnology professional

Rosemary Wareham, nurse practitioner, Minute Clinic CVS pharmacy Solana Beach [Added: 4:20 am, 3/16/10]

Jeff Watkins, CEO, aTyr Pharma

Toni Wayne, vice president of human resources, Prometheus Laboratories

Robin Weaver, consultant, Regulatory Writing Services [Added: 10 pm, 3/15/10]

Ty Webb, board member, SLA [Added: 9:30 pm, 3/23/10]

Cheryl White, corporate vice president, quality, Baxter International [Added: 8:35 pm, 3/14/10]

Karl Wiersholm, interim CFO

Mark S. Wilson, senior advisor, Rondaxe Pharma [Updated: 9:25 am, 3/15/10]

Bob Wolfert, chief scientific officer, diaDexus [Added: 6:10 am, 3/24/10]

Timothy Wollaeger, managing director, Sanderling Ventures

Kenneth Woolcott, president and founder, Six Degrees Capital

Marie Jeanne Yerna, scientific marketing manager, Beckman Coulter [Added: 4:20 am, 3/16/10]

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.